- Home
- TARS vs ENVA Comparison
TARS vs ENVA Comparison
Compare TARS & ENVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TARS
- ENVA
- Stock Information
- Founded
- TARS 2016
- ENVA 2011
- Country
- TARS United States
- ENVA United States
- Employees
- TARS N/A
- ENVA N/A
- Industry
- TARS Medicinal Chemicals and Botanical Products
- ENVA Finance: Consumer Services
- Sector
- TARS Health Care
- ENVA Finance
- Exchange
- TARS Nasdaq
- ENVA Nasdaq
- Market Cap
- TARS 2.8B
- ENVA 2.6B
- IPO Year
- TARS 2020
- ENVA N/A
- Fundamental
- Price
- TARS $67.56
- ENVA $119.28
- Analyst Decision
- TARS Strong Buy
- ENVA Strong Buy
- Analyst Count
- TARS 7
- ENVA 5
- Target Price
- TARS $69.43
- ENVA $138.20
- AVG Volume (30 Days)
- TARS 613.1K
- ENVA 247.5K
- Earning Date
- TARS 11-04-2025
- ENVA 10-23-2025
- Dividend Yield
- TARS N/A
- ENVA N/A
- EPS Growth
- TARS N/A
- ENVA 73.62
- EPS
- TARS N/A
- ENVA 10.82
- Revenue
- TARS $295,521,000.00
- ENVA $1,414,115,000.00
- Revenue This Year
- TARS $139.46
- ENVA $161.74
- Revenue Next Year
- TARS $49.91
- ENVA $15.60
- P/E Ratio
- TARS N/A
- ENVA $11.02
- Revenue Growth
- TARS 254.45
- ENVA 20.78
- 52 Week Low
- TARS $38.51
- ENVA $79.41
- 52 Week High
- TARS $76.81
- ENVA $130.34
- Technical
- Relative Strength Index (RSI)
- TARS 54.32
- ENVA 56.69
- Support Level
- TARS $65.30
- ENVA $106.46
- Resistance Level
- TARS $74.83
- ENVA $127.82
- Average True Range (ATR)
- TARS 2.87
- ENVA 4.47
- MACD
- TARS -0.99
- ENVA 1.52
- Stochastic Oscillator
- TARS 19.64
- ENVA 65.56
About TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis.
About ENVA Enova International Inc.
Enova International Inc provides online financial services, including short-term consumer loans, line of credit accounts, and installment loans to customers mainly in the United States and and Brazil. Consumers apply for credit online, the company's technology platforms process the applications, and transactions are completed quickly and efficiently. Its customers are predominantly retail consumers and small businesses. Enova markets its financing products under the names CashNetUSA, NetCredit, OnDeck, Headway Capital, and Simplic. The company also operates a money transfer platform under the name Pangea. Geographically, the company generates a majority of its revenue from its business in the United States and the rest from other international countries.